Abbott Laboratories (Pakistan) (KAR:ABOT) Change In Receivables : ₨-694 Mil (TTM As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Change In Receivables?

Abbott Laboratories (Pakistan)'s change in receivables for the quarter that ended in Mar. 2024 was ₨-741 Mil. It means Abbott Laboratories (Pakistan)'s Accounts Receivable increased by ₨741 Mil from Dec. 2023 to Mar. 2024 .

Abbott Laboratories (Pakistan)'s change in receivables for the fiscal year that ended in Dec. 2023 was ₨-782 Mil. It means Abbott Laboratories (Pakistan)'s Accounts Receivable increased by ₨782 Mil from Dec. 2022 to Dec. 2023 .

Abbott Laboratories (Pakistan)'s Accounts Receivable for the quarter that ended in Mar. 2024 was ₨2,306 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Abbott Laboratories (Pakistan)'s Days Sales Outstanding for the three months ended in Mar. 2024 was 13.13.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Abbott Laboratories (Pakistan)'s liquidation value for the three months ended in Mar. 2024 was ₨-4,554 Mil.

Abbott Laboratories (Pakistan) Change In Receivables Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Change In Receivables Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

1.98

-55.76

-460.90

-1,135.64

-781.81

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-829.00	-92.08	-425.13	564.39	-741.42

Abbott Laboratories (Pakistan) Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-694 Mil.

Abbott Laboratories (Pakistan) (KAR:ABOT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Abbott Laboratories (Pakistan)'s Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2305.929	/	16028.928	*	91
=	13.13

2. In Ben Graham's calculation of liquidation value, Abbott Laboratories (Pakistan)'s accounts receivable are only considered to be worth 75% of book value:

Abbott Laboratories (Pakistan)'s liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3423.253	-	16270.292	+	0.75 * 2305.929	+	0.5 * 13126.599
=	-4,554

Abbott Laboratories (Pakistan) Change In Receivables Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines